Selinexor 60 mg
XPORT-MF-044
Phase 2 small_molecule active
Quick answer
Selinexor 60 mg for Myelofibrosis is a Phase 2 program (small_molecule) at Karyopharm Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Karyopharm Therapeutics
- Indication
- Myelofibrosis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active